Integrating Genetic Domestication and Model-Guided Kill-Switch Engineering in a Non-Model Bacterial Therapeutic

Engineered bacteria offer programmable cancer immunotherapies, but engineering tractability does not always align with therapeutic suitability.

By Jeong, Namboothiri, Femi-Olatunji +3Oct 20, 2026

Score████░░░░░░4.4

Caveats

Preprint; not yet peer reviewed.

VerdictWorth a reader's time today.

Read the original PDF

Abstract

Engineered bacteria offer programmable cancer immunotherapies, but engineering tractability does not always align with therapeutic suitability. The attenuated intracellular vaccine strain Brucella melitensis {Delta}vjbR (Bm{Delta}vjbR) shows promise as an immunotherapy chassis, yet its translation requires reliable control and containment systems that remain difficult to engineer with the limited genetic tools available. Here, we establish a genetic domestication workflow that connects genetic part generation and quantitative evaluation with model-guided circuit design. Through mutagenesis and screening, we generated and characterized genetic part libraries, including promoters spanning two orders of magnitude in activity, a panel of ribosome-binding sites, and highly functional terminators. We also evaluated fluorescent reporters, plasmid compatibility, and three inducible regulatory systems. These host-specific measurements informed mathematical modeling to guide the selection of a doxycycline-inducible Cas9/gRNA kill-switch architecture before construction. Experimental validation demonstrated inducible control both in vitro and in vivo: doxycycline reduced viable Bm{Delta}vjbR below the assay detection limit in vitro and decreased bacterial burden in mouse liver by approximately 91%. To our knowledge, this work establishes the first systematic genetic domestication of Bm{Delta}vjbR and the first containment circuit in this strain. The resulting workflow provides an extensible framework for domesticating and engineering other non-model bacteria.

Y. Jeong, H. R. Namboothiri, O. Femi-Olatunji, P. de Figueiredo, C. Agca, C. Y. Hu

The editor's rubric

Heuristic review

Leverage3 / 5: A method or resource many groups across the field will adopt within a year.; 24% of this desk’s rubric
Magnitude3 / 5: Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.; 16% of this desk’s rubric
Evidence3 / 5: Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.; 20% of this desk’s rubric
Novelty2 / 5: A new combination of known ideas.; 20% of this desk’s rubric
Trajectory3 / 5: A clear path to scale.; 10% of this desk’s rubric
Stakes3 / 5: Meaningful benefit to many people within a few years.; 10% of this desk’s rubric

Dimension	Level	Weight	What that level means
Leverage	███░░ 3	24%	A method or resource many groups across the field will adopt within a year.
Magnitude	███░░ 3	16%	Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
Evidence	███░░ 3	20%	Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
Novelty	██░░░ 2	20%	A new combination of known ideas.
Trajectory	███░░ 3	10%	A clear path to scale.
Stakes	███░░ 3	10%	Meaningful benefit to many people within a few years.

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: method (we report); breadth (programmable); gains (orders of magnitude); verification (error bars, experimental validation); scale (orders of magnitude); stakes (major disease, prevention or cure).

How the score was computed

rank-2026-10-18

Score████░░░░░░4.4

Score = 10 × (75% × adjusted merit / 10 + 15% × attention + 10% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit: 5.6 / 10; Weighted rubric, evidence-gated.
Adjusted merit: 4.7 / 10; Shrunk toward the desk prior by editor confidence (46%).
Attention: 0%; Citations, upvotes, points, mentions.
Freshness: 88%; Half-life decay since publication.

No attention signals recorded yet.

The record

Reviewed by heuristic-v7 on Oct 21, 2026, 05:48 UTC. Paper type: method.
Categories: synthetic biology
TOP, No.5 in the Biology edition of October 21, 2026.